Charles Schwab Investment Management Inc Landos Biopharma, Inc. Transaction History

Charles Schwab Investment Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.6 - $1.5 $6,209 - $15,523	-10,349 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$1.44 - $5.22 $5,199 - $18,849	-3,611 Reduced 25.87%	10,349 $16,000
Q3 2021 Nov 16, 2021	BUY	$9.77 - $15.77 $5,060 - $8,168	518 Added 3.85%	13,960 $204,000
Q1 2021 May 17, 2021	BUY	$9.47 - $16.26 $127,295 - $218,566	13,442 New	13,442 $130,000

Ticker LABP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,254,900
Description
Landos Biopharma, Inc., a clinical-stage biopharmaceutical company, discovers and develops oral therapeutics for patients with autoimmune diseases. The company's lead product candidate in development include omilancor, a gut-restricted oral therapeutic candidate that targets lanthionine synthetase C-like protein 2 (LANCL2) for the treatment of u...

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Charles Schwab Investment Management Inc with notifications on news.